Titan Biotech Ltd.
| BSE: 524717 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE150C01011 |
| BSE 00:00 | 30 Oct | 127.05 |
-5.95 (-4.47%) |
OPEN
130.60 |
HIGH
133.00 |
LOW
126.35 |
| NSE 05:30 | 01 Jan | Titan Biotech Ltd |
| OPEN | 130.60 |
| PREVIOUS CLOSE | 133.00 |
| VOLUME | 66346 |
| 52-Week high | 194.15 |
| 52-Week low | 27.25 |
| P/E | 4.70 |
| Mkt Cap.(Rs cr) | 105 |
| Buy Price | 127.05 |
| Buy Qty | 95.00 |
| Sell Price | 127.05 |
| Sell Qty | 110.00 |
Titan Biotech Ltd. (TITANBIOTECH) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 772.75 | 4.00 | 0.52 | 13266.48 |
| Cipla | 754.10 | -7.80 | -1.02 | 12659.15 |
| Sun Pharma.Inds. | 465.75 | 9.00 | 1.97 | 12531.93 |
| Dr Reddy's Labs | 4887.95 | -54.50 | -1.10 | 11850.40 |
| Lupin | 908.40 | -15.50 | -1.68 | 11025.66 |
| Apollo Hospitals | 2119.25 | 31.95 | 1.53 | 9794.50 |
| Glenmark Pharma. | 475.20 | 5.45 | 1.16 | 6712.63 |
| Alkem Lab | 2634.25 | -38.10 | -1.43 | 6677.08 |
| Cadila Health. | 417.70 | 6.50 | 1.58 | 6347.40 |
| Torrent Pharma. | 2564.70 | 45.15 | 1.79 | 6168.44 |
| Divi's Lab. | 3140.35 | 32.45 | 1.04 | 5310.57 |
| Ipca Labs. | 2313.10 | -36.70 | -1.56 | 4337.82 |
| Piramal Enterp. | 1261.55 | 46.30 | 3.81 | 4219.19 |
| Alembic Pharma | 963.45 | -6.30 | -0.65 | 4132.55 |
| Abbott India | 15302.05 | 140.05 | 0.92 | 4093.14 |
| Glaxosmi. Pharma | 1465.65 | -16.00 | -1.08 | 3224.68 |
| Jubilant Life | 727.90 | -11.75 | -1.59 | 3139.90 |
| Sanofi India | 8003.75 | -16.00 | -0.20 | 3070.60 |
| Laurus Labs | 319.20 | -11.15 | -3.38 | 2797.34 |
| Nectar Lifesci. | 19.45 | -0.20 | -1.02 | 2362.80 |
Quick Links for Titan Biotech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
